Key facts
- This page summarizes Victor M. Clavelli's Form 4 filing for OptiNose, Inc. (OPTN).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 19 Dec 2022, 12:48.
Victor M. Clavelli - 15 Dec 2022 Form 4 Insider Report for OptiNose, Inc. (OPTN)
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- OPTN
- Reported as of
- 15 Dec 2022
- Net transaction value
- -$5,422
- SEC form
- 4
- Accepted by SEC
- 19 Dec 2022, 12:48:22 UTC
- Prior SEC filing
- 20 Sep 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Anthony Krick, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Victor M. Clavelli filed Form 4 for OptiNose, Inc. (OPTN) on 19 Dec 2022.
Change
- Previous filing in this sequence was filed on 20 Sep 2022.
- Current net transaction value: -$5,422.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OPTN
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +2,500
- Change %
- +1.2%
- Price
- $0.000000
- Shares after
- 203,163
- Date
- 15 Dec 2022
- Ownership
- Direct
- Footnotes
- F1
OPTN
transaction
Common Stock
Sale
- Transaction value
- $5,422
- Shares
- -3,208
- Change %
- -1.6%
- Price
- $1.69
- Shares after
- 199,955
- Date
- 16 Dec 2022
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents the grant of performance-based restricted stock units (Performance RSUs) on March 6, 2020. Fifty percent (50%) of the Performance RSUs vested on June 15, 2022, upon achievement of certain milestones in connection with the Company's development programs. The balance vests in eight equal quarterly installments, subject to continued service with the Issuer. Each Performance RSU represents the right to receive one share of common stock of OptiNose, Inc.
Footnote F2
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted share units. This sale is mandated by the issuer's award agreement under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person